Tern Therapeutics

Washington, United States

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

$15.0M raised

Aug 2024

Seed

Biotechnology Medical Therapeutics

Top Investors

ATW PartnersSteve Oliveira

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Tern Therapeutics

How much funding has Tern Therapeutics raised?

Tern Therapeutics has raised $15.0M in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Who are Tern Therapeutics's investors?

Tern Therapeutics's investors include ATW Partners, Steve Oliveira.

Where is Tern Therapeutics headquartered?

Tern Therapeutics is headquartered in Washington, United States.

What does Tern Therapeutics do?

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

What stage is Tern Therapeutics at?

Tern Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 27, 2024.

MLA

"Tern Therapeutics — Funding & Investors." VCBacked, August 27, 2024, https://www.vcbacked.co/company/tern-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2024). Tern Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/tern-therapeutics

Wikipedia (cite web)

{{cite web |title=Tern Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tern-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 27, 2024.

Similar Companies in Biotechnology